July - September 2012
* Biotie completed a directed share issue of EUR 20 million to institutional and strategic investors.
* Lundbeck made a EUR 10 Million equity investment in Biotie with a 25% premium and the parties amended the Selincro licensing agreement regarding territories outside the EU and US.